Barclays PLC Clear Point Neuro, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Barclays PLC holds 66,436 shares of CLPT stock, worth $941,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,436

Previous 5,674 1070.88%

Holding current value

$941,398

Previous $64,000 1496.88%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$10.74 - $16.68 $652,583 - $1.01 Million	60,762 Added 1070.88%	66,436 $1.02 Million
Q3 2024 Nov 15, 2024	BUY	$5.3 - $13.18 $5,877 - $14,616	1,109 Added 24.29%	5,674 $64,000
Q2 2024 Aug 14, 2024	SELL	$5.25 - $6.73 $60,868 - $78,027	-11,594 Reduced 71.75%	4,565 $25,000
Q1 2024 May 15, 2024	SELL	$6.03 - $7.86 $92,650 - $120,768	-15,365 Reduced 48.74%	16,159 $110,000
Q4 2023 Feb 15, 2024	BUY	$4.46 - $7.07 $122,279 - $193,838	27,417 Added 667.57%	31,524 $214,000
Q3 2023 Nov 07, 2023	SELL	$5.01 - $7.09 $2,439 - $3,452	-487 Reduced 10.6%	4,107 $21,000
Q2 2023 Aug 03, 2023	SELL	$6.54 - $10.58 $47,251 - $76,440	-7,225 Reduced 61.13%	4,594 $33,000
Q1 2023 May 04, 2023	SELL	$7.33 - $10.63 $12,534 - $18,177	-1,710 Reduced 12.64%	11,819 $100,000
Q4 2022 Feb 13, 2023	BUY	$7.7 - $11.21 $98,413 - $143,275	12,781 Added 1708.69%	13,529 $115,000
Q3 2022 Nov 03, 2022	BUY	$9.82 - $16.49 $7,345 - $12,334	748 New	748 $8,000
Q2 2022 Aug 12, 2022	SELL	$7.09 - $13.65 $21,929 - $42,219	-3,093 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.8 - $11.6 $24,125 - $35,878	3,093 New	3,093 $32,000

Others Institutions Holding CLPT

# of Institutions

Shares Held

7.57M

Call Options Held

390K

Put Options Held

28.7K

View Full List

About ClearPoint Neuro, Inc.

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $347M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

More about CLPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account